Antiverse
Engineering the future of drug discovery
Antiverse has raised €17M across 4 funding rounds from 17 investors, most recently a Series A round in Mar 2026. Based in Cardiff, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€17M
€16,666,685
Funding rounds
4
Investors
17
distinct backers
Active since
2021-03
latest 2026-03
Funding by year
EUR raised per year · 2026 YTDAntiverse — funding by year — interactive chart.
Data table
| Antiverse — funding by year | |
|---|---|
| 2021 | €1.6M |
| 2023 | €2.8M |
| 2024 | €4.2M |
| 2026 | €8.0M |
Signals
High confidenceRaise-next likelihood45
base rate 44% for Series A
- ▼ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
- ▲ 4 rounds raised
- ▲ 9y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-03 | Series A | €8.0M | DBW,DOMiNO Ventures,i&i Biotech Fund,Innovation Investment Capital,Kadmos Capital | View deal → |
| 2024-10-16 | Seed | €4.2M | AngelHub,Existing investors,i&i Biotech Fund I,InnoSpark Ventures,Kadmos Capital,Tensor Ventures+1 more | View deal → |
| 2023-03-01 | Other | €2.8M | AngelHub,Deep Science Ventures,Development Bank of Wales,Ed Parkinson,InnoSpark Ventures,Kadmos Capital+2 more | View deal → |
| 2021-03-30 | Other | €1.6M | UK Innovation & Science Seed Fund | View deal → |